Media

Media Contact

Financial & General Press
Henri von Haartman
Director of Investor Relations
+46 768 665 011
+358 29 370 0150
hvh@nanoform.com

Pharmaceutical Press
Christian Jones
Chief Commercial Officer
+44 7804 474 771
+358 29 370 0150
christian.jones@nanoform.com

Press releases

• Regulatory May 28, 2020
  Nanoform Finland Plc has applied for its shares to be listed on Nasdaq First North Premier Growth Market Finland and Nasdaq First North Premier Growth Market Sweden
• Regulatory May 25, 2020
  Nanoform announces a fixed subscription price and publishes a prospectus for its contemplated IPO and dual listing of its shares on Nasdaq First North Premier Growth Markets in Finland & Sweden
• Regulatory May 11, 2020
  Nanoform intends to launch an initial public offering and dual listing on Nasdaq First North Premier Growth Markets in Finland & Sweden

All press releases

Follow us

• Twitter
• LinkedIn

Twitter

Tweets by @NanoformF